Pfizer Limited (BOM:500680)
India
· Delayed Price · Currency is INR | Market Cap | 220.51B |
| Revenue (ttm) | 24.82B |
| Net Income (ttm) | 8.54B |
| Shares Out | n/a |
| EPS (ttm) | 186.59 |
| PE Ratio | 25.83 |
| Forward PE | 26.19 |
| Dividend | 165.00 (3.44%) |
| Ex-Dividend Date | Jul 9, 2025 |
| Volume | 761 |
| Average Volume | 29,008 |
| Open | 4,757.00 |
| Previous Close | 4,734.55 |
| Day's Range | 4,752.50 - 4,834.95 |
| 52-Week Range | 4,156.65 - 5,987.65 |
| Beta | n/a |
| RSI | 50.22 |
| Earnings Date | May 30, 2026 |
About Pfizer
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo... [Read more]
Financial Performance
In fiscal year 2025, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.
Financial StatementsNews
Pfizer appoints Nilesh Pendse as vaccines category lead; Manikantan Seshadrinathan exits senior management
Pfizer Limited informed stock exchanges on January 20, 2026, about multiple changes in its senior management personnel, in compliance with...
Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands
Pfizer Limited on Thursday announced that it has entered into an exclusive supply and marketing agreement with Cipla for four...
Pfizer shares jump over 5% as Q2 profit rises 19% YoY on strong operational performance
Shares of Pfizer Ltd surged 5.83% to Rs 5,308 on Thursday, November 13, after the company reported a solid set...
Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY
Pfizer Ltd’s shares surged 5.4% to ₹5,385 in early trade on Thursday after the pharmaceutical company reported robust first-quarter results for FY26. The company’s net profit grew 27.2% year-on-year (...
Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India
Shares of Pfizer Limited rose 2.07% to Rs 5,165.50 on Tuesday, August 12, following the company’s announcement of the launch of its next-generation 20-valent Pneumococcal Polysaccharide Conjugate Vacc...
Pfizer Transcript: AGM 2025
The AGM celebrated 75 years of operations, highlighted robust financial growth, and announced a special dividend. Strategic focus included new product launches, sustainability, and expanding local manufacturing, while addressing shareholder queries and regulatory compliance.
Pfizer Transcript: AGM 2024
The AGM highlighted a challenging year with an 11% sales decline due to one-off events, but key brands delivered strong growth and the company returned to positive momentum in Q4 FY24 and Q1 FY25. Strategic focus remains on new launches, local manufacturing, ESG, and stakeholder engagement.